Vicore Pharma Holding AB (STU:6Y4) FFO


STU:6Y4 Vicore Pharma Holding AB STU:6Y4
30 GF Score
Price €1.16
! 5 Warning Signs
View Full Analysis

What is Vicore Pharma Holding AB FFO?

FFO (Funds from operations) only applies to REITs.

STU:6Y4
30GF Score
Vicore Pharma Holding AB STU:6Y4
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vicore Pharma Holding AB Business Description

Other Exchanges VICO:Sweden
Address Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
30GF Score

Get the complete analysis for STU:6Y4

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.16
Price